KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Discontinued Operations (2016 - 2025)

Encompass Health (EHC) has disclosed Cash from Discontinued Operations for 17 consecutive years, with 1100000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Discontinued Operations rose 83.33% year-over-year to 1100000.0, compared with a TTM value of 1400000.0 through Dec 2025, up 54.84%, and an annual FY2025 reading of 1400000.0, up 54.84% over the prior year.
  • Cash from Discontinued Operations was 1100000.0 for Q4 2025 at Encompass Health, up from 600000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 134100000.0 in Q3 2021 and bottomed at 19900000.0 in Q3 2022.
  • Average Cash from Discontinued Operations over 5 years is 9626315.79, with a median of 700000.0 recorded in 2024.
  • The sharpest move saw Cash from Discontinued Operations soared 134200.0% in 2021, then tumbled 208.11% in 2023.
  • Year by year, Cash from Discontinued Operations stood at 17600000.0 in 2021, then tumbled by 121.02% to 3700000.0 in 2022, then crashed by 208.11% to 11400000.0 in 2023, then soared by 105.26% to 600000.0 in 2024, then skyrocketed by 83.33% to 1100000.0 in 2025.
  • Business Quant data shows Cash from Discontinued Operations for EHC at 1100000.0 in Q4 2025, 600000.0 in Q3 2025, and 1200000.0 in Q2 2025.